We’ve also produced a folding wallet card for people living with scleroderma to share with their dentists. You can find this here. It will soon be available through the SRUK website.
Scleroderma
There are 2.5 million people worldwide who are diagnosed with scleroderma, including, approximately, 19,000 in the UK. Scleroderma is an auto-immune condition characterised by the production of excess collagen, which leads to fibrosis of the skin and internal organs causing thickening and hardening.
Scleroderma can be experienced very differently depending on the type of scleroderma a person has (localised or systemic). Localised scleroderma mainly affects the skin, whilst systemic scleroderma, also known as systemic sclerosis, (itself split into 2 types – limited and diffuse) has a more widespread impact on the body and may also include internal organ involvement, causing sometimes life-threatening, problems with the heart, lungs, kidneys, the GI tract, and the vascular system – these are the issues that clinicians are most concerned to attend to.
Many people with scleroderma, however, live for many years with the condition which, as time passes, can have a significant impact on the mouth and teeth causing microstomia (limited mouth opening), muscular atrophy, thin lips, xerostomia (dry mouth), oral fibrosis, ulcers, restricted tongue mobility, temporomandibular joint problems, and salivary gland disorders. These issues tend to be overlooked when it comes to the diagnosis and treatment of scleroderma, but they can have a very negative impact on people’s quality of life.
One of the key aims of the project is to understand the perspectives of both patients and practitioners and to try to generate strategies to create more awareness and understanding of the oral and dental problems associated with scleroderma.